447 related articles for article (PubMed ID: 30928335)
1. Indeterminate nodules by the Bethesda system for reporting thyroid cytopathology in Israel: Frequency, and risk of malignancy after reclassification of follicular thyroid neoplasm with papillary-like features.
Rosenblum RC; Shtabsky A; Marmor S; Trejo L; Yaish I; Barnes S; Yehuda M; Stern N; Silman Z; Tordjman KM
Eur J Surg Oncol; 2019 Jul; 45(7):1182-1187. PubMed ID: 30928335
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
Zhou H; Baloch ZW; Nayar R; Bizzarro T; Fadda G; Adhikari-Guragain D; Hatem J; Larocca LM; Samolczyk J; Slade J; Rossi ED
Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185
[TBL] [Abstract][Full Text] [Related]
3. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
Kopczyński J; Suligowska A; Niemyska K; Pałyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858
[TBL] [Abstract][Full Text] [Related]
4. CLINICAL IMPACT OF NON-INVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES ON THE RISK OF MALIGNANCY IN THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A META-ANALYSIS OF 14,153 RESECTED THYROID NODULES.
Vuong HG; Tran TTK; Bychkov A; Jung CK; Nakazawa T; Kakudo K; Katoh R; Kondo T
Endocr Pract; 2019 May; 25(5):491-502. PubMed ID: 30657357
[No Abstract] [Full Text] [Related]
5. Impact of the Reclassification of "Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma" to "Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features" on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution's Experience.
Lau RP; Paulsen JD; Brandler TC; Liu CZ; Simsir A; Zhou F
Am J Clin Pathol; 2017 Dec; 149(1):50-54. PubMed ID: 29272354
[TBL] [Abstract][Full Text] [Related]
6. RISK OF MALIGNANCY IN THYROID CYTOLOGY: THE IMPACT OF THE RECLASSIFICATION OF NONINVASIVE FOLLICULAR THYROID NEOPLASM WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP).
Ventura M; Melo M; Fernandes G; Carrilho F
Endocr Pract; 2019 Jul; 25(7):642-647. PubMed ID: 30865528
[No Abstract] [Full Text] [Related]
7. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
[TBL] [Abstract][Full Text] [Related]
8. Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries.
Bychkov A; Keelawat S; Agarwal S; Jain D; Jung CK; Hong S; Lai CR; Satoh S; Kakudo K
Pathology; 2018 Jun; 50(4):411-417. PubMed ID: 29631726
[TBL] [Abstract][Full Text] [Related]
9. Effect of the Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision on Indian Thyroid Fine-Needle Aspiration Practice.
Rana C; Ramakant P; Goel D; Singh A; Singh K; Babu S; Mishra A
Am J Clin Pathol; 2021 Jul; 156(2):320-327. PubMed ID: 33608707
[TBL] [Abstract][Full Text] [Related]
10. Incidence of noninvasive follicular thyroid neoplasm with papillary-like nuclear features and change in risk of malignancy for "The Bethesda System for Reporting Thyroid Cytology".
Sung S; Margolskee E; Chen D; Tiscornia-Wasserman P
J Am Soc Cytopathol; 2019; 8(3):133-140. PubMed ID: 31097289
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features and the risk of malignancy in The Bethesda System for the Reporting of Thyroid Cytopathology.
Elliott Range D; Jiang XS
Diagn Cytopathol; 2020 Jun; 48(6):531-537. PubMed ID: 32167682
[TBL] [Abstract][Full Text] [Related]
12. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
[TBL] [Abstract][Full Text] [Related]
13. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
14. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
Özkara SK; Bayrak BY; Turan G
Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features reclassification and its impact on thyroid malignancy rate and treatment.
Mao ML; Joyal T; Picado O; Kerr D; Lew JI; Farrá JC
J Surg Res; 2018 Oct; 230():47-52. PubMed ID: 30100039
[TBL] [Abstract][Full Text] [Related]
16. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
[TBL] [Abstract][Full Text] [Related]
17. Impact of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features on Revised Bethesda System Malignancy Rates at a Single Institution.
Linhares SM; Whitfield BW; Lee AF; Gordillo D; Picado O; Jeraq M; Farrá JC; Lew JI
J Surg Res; 2020 Nov; 255():152-157. PubMed ID: 32563006
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group.
Rossi ED; Mehrotra S; Kilic AI; Toslak IE; Lim-Dunham J; Martini M; Fadda G; Lombardi CP; Larocca LM; Barkan GA
Cancer Cytopathol; 2018 Jan; 126(1):27-35. PubMed ID: 29024469
[TBL] [Abstract][Full Text] [Related]
19. The influence of the reclassification of NIFTP as an uncertain tumour on risk of malignancy for the diagnostic categories according to the Bethesda system for reporting thyroid cytopathology.
Kopczyński J; Suligowska A; Niemyska K; Palyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
Endokrynol Pol; 2019; 70(3):232-236. PubMed ID: 30845342
[TBL] [Abstract][Full Text] [Related]
20. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
Li W; Sciallis A; Lew M; Pang J; Jing X
Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
